Sai Prasamma Mannem
Internal Medicine · Bellevue, WANPI 1043491129
Payments from drug & device makers
Across 127 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$735
- Novo Nordisk$477
- Mayne Pharma Commercial LLC$249
- Bausch Health US, LLC$207
- Takeda Pharmaceuticals U.S.A., Inc.$162
- Bayer$135
- plus $834 from 22 others
What the payments were for
- Food & beverage$2,800100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $735 |
| Novo Nordisk | 23 | $477 |
| Mayne Pharma Commercial LLC | 16 | $249 |
| Bausch Health US, LLC | 10 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $162 |
| Bayer | 6 | $135 |
| Johnson & Johnson | 3 | $102 |
| Phadia US Inc. | 4 | $96 |
| Kowa Pharmaceuticals America, Inc. | 2 | $64 |
| Abbott | 2 | $58 |
| Hologic Sales And Service, LLC | 2 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $49 |
| Exact Sciences | 2 | $47 |
| Philips North America LLC | 1 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Seqirus USA Inc | 1 | $25 |
| Agile Therapeutics, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Amgen | 1 | $24 |
| Bardy Diagnostics, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| BD | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
| GSK | 1 | $16 |
| Pfizer | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,800 in reported general payments places this provider in the 90th percentile of 2,038 internal medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 29 | $499 |
| Losartan Potassium | 22 | $392 |
| Levothyroxine Sodium | 25 | $350 |
| Simvastatin | 11 | $267 |
| Atorvastatin Calcium | 20 | $166 |
| Lisinopril | 16 | $59 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bellevue
- Lawrence LoebBellevue$784K
- Gary SchusterBellevue$16K
- Allen GeltzerBellevue$14K
- Tatyana KutsyBellevue$13K
- Sabrina BenjaminOlympia$7.9M
- Ryan AhernSeattle$7.3M
- Eric KleinOlympia$2.4M
- Scott RamseySeattle$2M
- Vidya MenonTacoma$1.8M
- Peter ShalitSeattle$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.